Purple Biotech (PPBT) Current Leases (2019 - 2026)
Purple Biotech (PPBT) posted quarterly Current Leases of $184000.0 for Q1 2026, up 34.31% year-over-year from $137000.0 in Q1 2025, and down 24.59% quarter-over-quarter from $244000.0 in Q4 2025.
Purple Biotech (PPBT) Current Leases (2019 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Current Leases for 8 consecutive years, with $184000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 34.31% year-over-year to $184000.0; the TTM figure through Mar 2026 stood at $184000.0 (up 34.31% YoY), while the FY2025 annual figure was $244000.0, up 33.33% from the prior year.
- Current Leases declined to $184000.0 in Q1 2026 per PPBT's latest filing, from $244000.0 in the prior quarter.
- Across five years, Current Leases topped out at $244000.0 in Q4 2025 and bottomed at $103000.0 in Q2 2025.
- Historically, Current Leases has averaged $184117.6 across 5 years, with a median of $186000.0 in 2024.
- Annual changes were most pronounced in 2025 — Current Leases tumbled 43.41% — and 2026, when it soared 34.31%.
- Purple Biotech's Current Leases stood at $194000.0 in 2022, then retreated by 3.09% to $188000.0 in 2023, then slipped by 2.66% to $183000.0 in 2024, then jumped by 33.33% to $244000.0 in 2025, then declined by 24.59% to $184000.0 in 2026.
- Business Quant data shows PPBT's Current Leases at $184000.0 in Q1 2026, $244000.0 in Q4 2025, and $207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Purple Biotech | 133.62 | 133.62 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 184,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 199,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 199,000.00 |